BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21509480)

  • 21. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study.
    Suzuki N; Matsuki E; Araumi A; Ashitomi S; Watanabe S; Kudo K; Ichikawa K; Inoue S; Watanabe M; Ueno Y; Ishizawa K; Kayama T; Konta T
    Sci Rep; 2020 Mar; 10(1):5570. PubMed ID: 32221372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study.
    Cooksley NA; Atkinson D; Marks GB; Toelle BG; Reeve D; Johns DP; Abramson MJ; Burton DL; James AL; Wood-Baker R; Walters EH; Buist AS; Maguire GP
    Respirology; 2015 Jul; 20(5):766-74. PubMed ID: 25704620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
    van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
    BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease.
    Kim MY; Boo S; Yoo M; Lee J; Kang NR
    Int Urol Nephrol; 2017 Jul; 49(7):1225-1232. PubMed ID: 28386744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk.
    Guerra S; Sherrill DL; Venker C; Ceccato CM; Halonen M; Martinez FD
    Thorax; 2009 Oct; 64(10):894-900. PubMed ID: 19581277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary function abnormalities in adult patients with acute exacerbation of bronchiectasis: A retrospective risk factor analysis.
    Ma Y; Niu Y; Tian G; Wei J; Gao Z
    Chron Respir Dis; 2015 Aug; 12(3):222-9. PubMed ID: 25882894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema.
    Omori H; Tsuji M; Sata K; Iyonaga C; Narimatsu A; Mihara S; Marubayashi T; Tomiguchi S; Nomori H; Kohrogi H; Katoh T
    Respirology; 2009 May; 14(4):551-8. PubMed ID: 19386068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of endothelial function in patients with COPD.
    Clarenbach CF; Senn O; Sievi NA; Camen G; van Gestel AJ; Rossi VA; Puhan MA; Thurnheer R; Russi EW; Kohler M
    Eur Respir J; 2013 Nov; 42(5):1194-204. PubMed ID: 23429917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama Study.
    Matsumoto K; Seki N; Fukuyama S; Moriwaki A; Kan-o K; Matsunaga Y; Noda N; Yoshida M; Koto H; Takata S; Nakanishi Y; Kiyohara Y; Inoue H;
    Respir Investig; 2015 Jan; 53(1):22-9. PubMed ID: 25542600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.
    Donovan LM; Rise PJ; Carson SS; Feemster LC; Griffith MF; Kapur VK; Krishnan JA; Lindenauer PK; Mularski RA; Naureckas ET; Palen BN; Parsons EC; Spece LJ; Vitiello MV; Au DH;
    Ann Am Thorac Soc; 2017 Dec; 14(12):1836-1843. PubMed ID: 28825846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of cigarette smoking on decline in forced expiratory volume in 1s relative to severity of airflow obstruction in a Japanese general population: The Yamagata-Takahata study.
    Sato K; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Nemoto T; Sato M; Nakano H; Machida H; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Yamamoto T; Watanabe T; Konta T; Ueno Y; Kato T; Kayama T; Kubota I
    Respir Investig; 2018 Mar; 56(2):120-127. PubMed ID: 29548649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of diabetes mellitus in individuals with airflow obstruction in a Japanese general population: The Yamagata-Takahata Study.
    Machida H; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Sato K; Nakano H; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Yamamoto T; Watanabe T; Konta T; Ueno Y; Kato T; Kayama T; Kubota I
    Respir Investig; 2018 Jan; 56(1):34-39. PubMed ID: 29325679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.
    Johnston AK; Mannino DM; Hagan GW; Davis KJ; Kiri VA
    Thorax; 2008 Jul; 63(7):599-605. PubMed ID: 18245145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan.
    Omori H; Kaise T; Suzuki T; Hagan G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():873-80. PubMed ID: 27217740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
    Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.